TY - JOUR
T1 - Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus
AU - Groeneveld, O.
AU - Reijmer, Y.
AU - Heinen, R.
AU - Kuijf, H.
AU - Koekkoek, P.
AU - Janssen, J.
AU - Rutten, G.
AU - Kappelle, L.
AU - Biessels, G.
N1 - Funding Information:
Yael Reijmer receives funding from Alzheimer Nederland and ZonMw/Memorabel (grant # 733050503 ) and a Young Talent Fellowship from the Brain Center Rudolf Magnus of the University Medical Center Utrecht.
Publisher Copyright:
© 2018 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University
PY - 2018
Y1 - 2018
N2 - Background and aims: The risk of mild cognitive impairment and dementia is increased in type 2 diabetes mellitus (T2DM). We aimed to identify the neuroanatomical correlates of mild cognitive impairment (MCI) and early dementia in patients with T2DM, using advanced multimodal MRI. Methods and results: Twenty-five patients (≥70 years) with T2DM and MCI (n = 22) or early dementia (n = 3) were included. The reference group consisted of 23 patients with T2DM with intact cognition. All patients underwent a 3 T MRI. Brain volumes and white matter hyperintensity volumes were obtained with automated segmentation methods. White matter connectivity was assessed with diffusion tensor imaging and fiber tractography. Infarcts and microbleeds were rated visually. Compared to patients without cognitive impairment, those with impairment had a lower grey matter volume (effect size: −0.58, p=0.042), especially in the right temporal lobe and subcortical brain regions (effect sizes: −0.45 to −0.91, false discovery rate corrected p < 0.05). White matter volume (effect size: −0.47, p = 0.11) and white matter connectivity (effect size: 0.55, p = 0.054) were also reduced in patients with versus without cognitive impairment, albeit not statistically significant. White matter hyperintensity volumes and occurrence of other vascular lesions did not differ between the two patient groups. Conclusion: In patients with T2DM, grey matter atrophy rather than vascular brain injury appears to be the primary imaging correlate of MCI and early dementia.
AB - Background and aims: The risk of mild cognitive impairment and dementia is increased in type 2 diabetes mellitus (T2DM). We aimed to identify the neuroanatomical correlates of mild cognitive impairment (MCI) and early dementia in patients with T2DM, using advanced multimodal MRI. Methods and results: Twenty-five patients (≥70 years) with T2DM and MCI (n = 22) or early dementia (n = 3) were included. The reference group consisted of 23 patients with T2DM with intact cognition. All patients underwent a 3 T MRI. Brain volumes and white matter hyperintensity volumes were obtained with automated segmentation methods. White matter connectivity was assessed with diffusion tensor imaging and fiber tractography. Infarcts and microbleeds were rated visually. Compared to patients without cognitive impairment, those with impairment had a lower grey matter volume (effect size: −0.58, p=0.042), especially in the right temporal lobe and subcortical brain regions (effect sizes: −0.45 to −0.91, false discovery rate corrected p < 0.05). White matter volume (effect size: −0.47, p = 0.11) and white matter connectivity (effect size: 0.55, p = 0.054) were also reduced in patients with versus without cognitive impairment, albeit not statistically significant. White matter hyperintensity volumes and occurrence of other vascular lesions did not differ between the two patient groups. Conclusion: In patients with T2DM, grey matter atrophy rather than vascular brain injury appears to be the primary imaging correlate of MCI and early dementia.
KW - Cognitive dysfunction
KW - Dementia
KW - Diffusion tensor imaging
KW - Mild cognitive impairment
KW - MRI
KW - Type 2 diabetes mellitus
UR - http://www.scopus.com/inward/record.url?scp=85055095443&partnerID=8YFLogxK
U2 - 10.1016/j.numecd.2018.07.008
DO - 10.1016/j.numecd.2018.07.008
M3 - Article
C2 - 30355471
AN - SCOPUS:85055095443
SN - 0939-4753
VL - 28
SP - 1253
EP - 1260
JO - Nutrition, Metabolism and Cardiovascular Diseases
JF - Nutrition, Metabolism and Cardiovascular Diseases
IS - 12
ER -